News
Results for Apr. 2011 - Sep. 2011 (November 9, 2011)
(119KB)
Results for Apr. 2011 - June. 2011 (August 10, 2011)
(120KB)
Results for Apr. 2010 - Mar. 2011 (May 11, 2011)
(138KB)
Results for Apr. - Dec. 2010 (February 9, 2011)
(120KB)
Results for Apr. - Sep. 2010 (November 10, 2010)
(133KB)
Topics and investment highlights
Highest Operating Income on Record
With 51 consolidated subsidiaries and 12 equity-method affiliates inside and outside Japan, Inabata is expanding its businesses globally. In the year ended March 31, 2011, the company achieved a record level of operating income at ¥7.9 billion due to the recovery of the global economy centered on Asia. The recovery in sales in Southeast Asia and Northeast Asia has greatly contributed to this performance, and Inabata continues to consider these regions as priority markets for business expansion.
Focus on Key Growth Businesses
Inabata’s performance is being driven by increased sales in the IT & Electronics Business and the Plastics Business backed by increased production of LCD televisions, solid demand for electronics and a recovery in automotive sales. In the Chemicals Business, the performance chemicals and life science businesses have performed favorably. In order to consolidate business and focus management resources on key growth businesses, the company transferred its shares in IK Pharmacy to Nihon Chouzai Co., Ltd. in February 2010. The company also invested in Maruishi Chemical Trading Co., Ltd. in June 2010, making it an equity-method affiliate.
With 51 consolidated subsidiaries and 12 equity-method affiliates inside and outside Japan, Inabata is expanding its businesses globally. In the year ended March 31, 2011, the company achieved a record level of operating income at ¥7.9 billion due to the recovery of the global economy centered on Asia. The recovery in sales in Southeast Asia and Northeast Asia has greatly contributed to this performance, and Inabata continues to consider these regions as priority markets for business expansion.
Focus on Key Growth Businesses
Inabata’s performance is being driven by increased sales in the IT & Electronics Business and the Plastics Business backed by increased production of LCD televisions, solid demand for electronics and a recovery in automotive sales. In the Chemicals Business, the performance chemicals and life science businesses have performed favorably. In order to consolidate business and focus management resources on key growth businesses, the company transferred its shares in IK Pharmacy to Nihon Chouzai Co., Ltd. in February 2010. The company also invested in Maruishi Chemical Trading Co., Ltd. in June 2010, making it an equity-method affiliate.
The projections contained within this document are based on certain conditions and assumptions decided upon by the management using data current as of the date the document was
published. Actual performance may differ greatly as a result of a variety of factors in the future
To view PDF files, you need to have Acrobat Reader installed in your computer.
If you don't have it, you can go to the download page by clicking on the button.
©Copyright Inabata & Co., Ltd.2012 All rights reserved.